Caris Life Sciences CEO on IPO debut, using AI to fight against cancer

30 Visioni
Published
David Dean Halbert, Caris Life Sciences chairman, founder and CEO, joins 'Squawk Box' to discuss the company's IPO debut, how the company uses AI technology to help diagnose and treat cancer,
Categoria
Oncology
Commenta per primo questo video.